当前位置:首页 - 行情中心 - 金陵药业(000919) - 财务分析 - 资产负债表

金陵药业

(000919)

  

流通市值:33.58亿  总市值:34.09亿
流通股本:5.03亿   总股本:5.11亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金912,076,558.411,249,401,659.221,260,814,808.441,495,023,241.06
应收票据及应收账款653,178,891.14621,113,047.43535,928,542.66467,223,203.49
其中:应收票据218,451,878.42221,836,546.68198,234,439.56201,841,353.21
应收账款434,727,012.72399,276,500.75337,694,103.1265,381,850.28
预付款项9,870,536.9712,280,73426,298,474.4418,704,065.8
其他应收款合计9,886,7839,428,771.8316,888,697.4729,198,895.64
存货261,064,676.34236,887,117.86230,821,957.47250,483,101.42
一年内到期的非流动资产-278,690,411.21276,290,753.67273,917,466
其他流动资产222,231,471.085,182,020.165,909,575.416,244,304.65
流动资产平衡项目0000
流动资产合计2,319,556,134.732,675,115,644.232,616,014,317.822,633,145,031.76
非流动资产:
长期股权投资265,622,562.1264,218,281.44263,273,740.91263,867,387.9
其他权益工具投资1,146,563.081,146,563.081,146,563.081,146,563.08
投资性房地产8,634,508.918,872,9079,111,305.099,350,062.6
固定资产1,224,799,280.141,231,917,250.591,247,215,477.311,259,349,140.53
在建工程91,178,096.8751,301,009.8652,742,083.6337,841,394.1
生产性生物资产1,395,681.781,452,406.651,508,791.711,565,176.77
使用权资产3,626,320.123,023,414.133,931,824.244,114,761.21
无形资产251,703,697.2253,508,689.21255,884,678.9258,443,245.31
商誉27,331,541.7927,331,541.7927,331,541.7927,331,541.79
长期待摊费用15,202,141.4116,429,334.7917,527,664.7718,256,845.28
递延所得税资产28,114,983.1225,679,239.6622,122,362.4427,588,532.38
其他非流动资产301,399,526.321,749,420.033,794,052.881,353,248
非流动资产平衡项目0000
非流动资产合计2,220,154,902.841,886,630,058.231,905,590,086.751,910,207,898.95
资产平衡项目0000
资产总计4,539,711,037.574,561,745,702.464,521,604,404.574,543,352,930.71
流动负债:
短期借款808,129.721,781,004.361,779,1801,475,846.64
应付票据及应付账款448,205,670.93428,204,026.93449,078,271.2454,040,233.16
其中:应付票据70,819,670.263,449,985.7767,791,147.9374,411,530.11
应付账款377,386,000.73364,754,041.16381,287,123.27379,628,703.05
预收款项1,838,735.583,376,908.71,573,898.231,628,587.7
合同负债18,584,207.7219,192,845.7825,108,647.8822,141,989.8
应付职工薪酬87,766,765.4795,088,727.2359,016,944.66112,187,835.5
应交税费42,439,278.3339,542,480.1759,972,881.2158,301,671.37
其他应付款合计213,720,005.65207,969,548.36201,449,357.91212,836,059.38
一年内到期的非流动负债1,238,837.95913,167.661,381,132.461,534,265.38
其他流动负债450,742.03456,910.481,503,124.51,270,513.19
流动负债平衡项目0000
流动负债合计815,052,373.38796,525,619.67800,863,438.05865,417,002.12
非流动负债:
租赁负债1,953,976.541,835,540.351,991,732.562,289,714.25
递延收益507,393.33547,255.39587,117.37626,979.39
递延所得税负债41,886,982.148,732,528.4241,942,919.4847,965,304.75
非流动负债平衡项目0000
非流动负债合计44,348,351.9751,115,324.1644,521,769.4150,881,998.39
负债平衡项目0000
负债合计859,400,725.35847,640,943.83845,385,207.46916,299,000.51
所有者权益(或股东权益):
实收资本(或股本)511,136,000511,136,000511,136,000510,400,000
资本公积480,983,653.51480,983,653.51480,983,653.51478,341,413.51
减:库存股26,994,24024,352,00026,994,24023,616,000
其他综合收益2,512,226.612,512,226.612,512,226.612,512,226.61
专项储备953,060.351,312,415.631,501,118.131,661,225.44
盈余公积399,604,682.31399,604,682.31399,604,682.31399,604,682.31
未分配利润1,672,484,208.361,702,796,701.921,668,859,290.251,625,274,179.99
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,040,679,591.143,073,993,679.983,037,602,730.812,994,177,727.86
少数股东权益639,630,721.08640,111,078.65638,616,466.3632,876,202.34
股东权益平衡项目0000
股东权益合计3,680,310,312.223,714,104,758.633,676,219,197.113,627,053,930.2
负债和股东权益合计4,539,711,037.574,561,745,702.464,521,604,404.574,543,352,930.71
公告日期2023-10-312023-08-192023-04-292023-03-24
审计意见(境内)标准无保留意见
TOP↑